MEDVi Semaglutide Reviews 2026: Cost, Complaints, and Whether the Injection Program Is Worth It
By the Weight Loss Provider Guide editorial team — an independent comparison resource for GLP-1 telehealth providers. Last verified: April 22, 2026. Estimated read time: 12 minutes.
Weight Loss Provider Guide is an independent comparison resource. If you use our links, we may earn a commission at no extra cost to you. This never affects our editorial recommendations. See our advertising disclosure.
Short version, before anything else. If you're here for MEDVi semaglutide reviews, this is the honest snapshot: MEDVi's compounded semaglutide injection program is real, the public price is $179 for month one and $299 per refill with no separate membership fee advertised, and MEDVi holds a 4.4 / 5 rating across 12,000+ Trustpilot reviews. It is also a compounded product — not FDA-approved as a finished drug — and MEDVi received an FDA warning letter on February 20, 2026 (letter #721455) over how it marketed those compounded medications. That doesn't make MEDVi a scam. It does make this a decision where the $179 hook is the easy part and the homework is what keeps you from getting surprised on month two.
We read MEDVi's live program page, current terms, cancellation and refund policy, and public communication response. We pulled the FDA warning letter from the FDA's own database. We looked at live Trustpilot and ConsumerAffairs snapshots. Every number on this page was verified on the date above. If MEDVi turns out to be the wrong fit by the time you finish reading, we'll tell you exactly where to go instead.
✅ What we actually verified (April 22, 2026)
- • $179 first month / $299 refill pricing (MEDVi's public semaglutide program page)
- • 72-hour cancellation rule (MEDVi's official cancellation and refund policy)
- • Named partner pharmacies: Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding (MEDVi's current terms)
- • FDA warning letter #721455, issued 02/20/2026 — promotional/misbranding concerns, no recall and no lot-specific safety finding
- • 12,000+ Trustpilot reviews at 4.4 / 5 • 1,860 ConsumerAffairs reviews at 3.4 / 5
Check MEDVi eligibility and today's semaglutide pricing
Start your free medical intake. First month is $179 at completion. HSA/FSA accepted. Refund if a clinician medically disqualifies you.
MEDVi semaglutide reviews — the short answer
MEDVi's semaglutide injection program is a real, low-entry-price cash-pay option. The deciding issues are not “does semaglutide work” — they are when you're actually charged, the cancellation and refund terms, compounded vs FDA-approved expectations, and how comfortable you are with MEDVi's current regulatory scrutiny.
| Factor | The short answer |
|---|---|
| Program type | Compounded semaglutide injection (not FDA-approved as a finished product) |
| Price, month 1 | $179 — includes clinician review, personalized plan, medication, shipping |
| When you're charged | At intake completion, per MEDVi's cancellation and refund policy |
| Refund if declined | Yes — MEDVi says a refund is issued if a clinician medically disqualifies you |
| Price, ongoing | $299 per refill cycle |
| Separate membership fee | None advertised on the current public pricing page |
| Support | 24/7 unlimited messaging with the MEDVi care team |
| Cancellation window | Must cancel at least 72 hours before your next billing date |
| Results guarantee | MEDVi's cancellation policy says "there is no guarantee of results or effectiveness" — get any "guarantee" claim in writing before enrolling |
| Best for | Cash-pay adults who want a fast bundled semaglutide start and are comfortable with compounded medication |
| Not best for | Anyone who needs FDA-approved semaglutide, wants to use insurance, or wants airtight refund language |
If that “best for” line sounds like you, the rest of this page removes the last reasons you haven't clicked yet. If the “not best for” line sounds like you, skip to Alternatives → and we'll route you cleanly.
What we actually verified about MEDVi semaglutide
Answer capsule: The one-line verdict: the price structure is clear and consistent; the guarantee language is contradictory between MEDVi's marketing and its cancellation policy; and MEDVi's regulatory history is a real factor to weigh, not a dealbreaker.
| Buying friction | What we verified | Status |
|---|---|---|
| Program type | Compounded semaglutide injection, not an FDA-approved finished product. MEDVi says on its site that compounded medications are not FDA approved. | ✅ Verified |
| Month 1 price | $179 for the first month, on MEDVi's current public semaglutide page. | ✅ Verified |
| Ongoing refill price | $299 per refill. | ✅ Verified |
| When you're charged | At intake completion. MEDVi's cancellation and refund policy states the subscription begins when the intake form is completed and the customer is charged at that time. | ✅ Verified |
| Refund on disqualification | If a clinician determines the patient is not medically eligible, MEDVi's policy states a refund is issued. | ✅ Verified |
| What the price includes | Physician review, personalized plan, 1:1 guidance, metabolic report, medication, and shipping. | ✅ Verified |
| Separate membership fee | Not advertised on the current public pricing page. ConsumerAffairs describes the program structure as a monthly membership — we frame this as bundled monthly program pricing. | 🟨 Mixed / clarify |
| Support availability | 24/7 unlimited messaging and appointments. | ✅ Verified |
| Who prescribes | OpenLoop Health's licensed U.S. clinicians make the prescribing decision after checkout. | ✅ Verified |
| Named pharmacy partners | MEDVi's current terms publicly name Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding as partner pharmacies. | ✅ Verified (current) |
| State availability | MEDVi's terms say "certain states." ConsumerAffairs reports 49 states excluding North Dakota; six states require a video visit first. | 🟨 Verify at checkout |
| Cancellation window | Must be received at least 72 hours before the next billing date. | ✅ Verified |
| Refund on cancellation | Refunds are generally not issued upon cancellation except when a clinician disqualifies the patient. | ✅ Verified |
| "Results guarantee" (5-month) | Contradictory evidence. MEDVi's cancellation policy says "there is no guarantee of results or effectiveness," while third parties describe a 5-month money-back guarantee minus 25% consultation fee. Get the exact terms in writing. | ⚠️ Contradictory — verify in writing |
| Public review footprint | Trustpilot: 4.4 / 5 across 12,000+ reviews. ConsumerAffairs: 3.4 / 5 across 1,860 reviews. | ✅ Verified |
| FDA warning letter | Issued February 20, 2026 (letter #721455): promotional/misbranding allegations. No recall, no lot-specific safety finding. MEDVi was one of 30+ companies warned. | ✅ Verified |
| MEDVi's response | MEDVi states the FDA-reviewed URL was medvi.io (not medvi.org), that it belonged to an affiliate agency using outdated copy, and that MEDVi updated marketing practices. | ✅ Verified |
| Marketing disclaimer | MEDVi's terms disclose that some content may be AI-generated or enhanced and that individuals in ads may be actors or models. | ✅ Verified |
| Multi-month pricing claims | Some affiliate pages mention $249/3-mo and $219/6-mo plans. This pricing does not appear on the main public page as of our check. | ⚠️ Not confirmed |
Who MEDVi semaglutide is for — and who should skip it
Answer capsule: MEDVi's compounded semaglutide injection program fits cash-pay adults who want a fast bundled start, who have decided on semaglutide (not tirzepatide), and who are comfortable with compounded medication. It is the wrong choice for anyone who needs FDA-approved semaglutide, wants insurance support, or wants ironclad written refund terms.
MEDVi may be a good fit if…
- You're paying cash — no GLP-1 coverage through insurance
- You've decided semaglutide (not tirzepatide) is your starting lane
- You want weekly injections, not daily oral tablets
- $179 fits your first-month budget and $299 fits ongoing
- You understand compounded medication is not FDA-approved as a finished product and you're okay with that
- You like HSA/FSA payment flexibility
- You can set a calendar reminder four days before every billing date
You may want an alternative if…
- You want FDA-approved semaglutide
- You want insurance-first support
- You want the cleanest possible compliance story
- You want more flexible refund expectations
- You want lower ongoing compounded semaglutide pricing
- You prefer oral tablets over weekly injections
Our honest admission, placed early
Specifically, if you want something different:
- FDA-approved semaglutide and insurance support → Ro is cleaner. See Alternatives →
- Lower ongoing compounded semaglutide pricing → Eden's public monthly pricing is lower than MEDVi's. See Alternatives →
- Oral semaglutide through MEDVi → Our MEDVi Pills Reviews covers the tablet program end-to-end.
- Tirzepatide instead of semaglutide → Our MEDVi Tirzepatide Reviews covers that program specifically.
See if you qualify for MEDVi's semaglutide program
Free medical intake. First month is $179 at completion. MEDVi's policy states a refund is issued if a clinician medically disqualifies you.
How much does MEDVi semaglutide really cost after month one?
Answer capsule: MEDVi's public semaglutide page lists $179 for the first month and $299 per refill. Independent reviews describe a roughly 28-day refill cadence — meaning about 13 charges per year rather than 12 if you stay enrolled. Budget for that cadence and you avoid the #1 billing complaint on review platforms.
The real year-one math (clearly labeled)
Review-reported scenario built from official $179/$299 prices plus independent review reports of a 4-week refill cadence. Treat as a planning estimate, not an official MEDVi figure.
| Line item | Cost | Notes |
|---|---|---|
| Month 1 (first cycle) | $179 | Intro pricing, one cycle only. Charged at intake completion per MEDVi's cancellation policy. |
| Refills 2–13 | $299 × ~12 = ~$3,588 | Based on reported 4-week (28-day) refill cadence |
| Year 1 total (estimate) | ~$3,767 | Assumes you stay enrolled all 12 calendar months |
Year-two pricing stays at $299 per refill. There's no year-two discount advertised on the public pricing page, and there's no price hike either — the refill rate is stable.
The 28-day cadence trap
What's bundled into the $299
Per MEDVi's own program page, the refill price includes:
- The compounded semaglutide injection
- Licensed U.S. clinician evaluation and prescription via OpenLoop Health
- A personalized titration plan
- 24/7 unlimited messaging with MEDVi's care team
- Free shipping
HSA, FSA, and insurance
See MEDVi's current semaglutide program details
Is MEDVi semaglutide legit — or a scam?
Answer capsule: MEDVi is a legitimate telehealth business with public pricing, public policies, named clinician and pharmacy partners, and a 12,000+ review footprint on Trustpilot at 4.4 / 5. It is not a scam. The reason people still search “MEDVi scam” is that a February 2026 FDA warning letter, a cluster of billing/refund complaints on ConsumerAffairs, and MEDVi's own terms disclosing AI-enhanced and model-based advertising content create enough uncertainty to justify a second look — which this section resolves.
What makes MEDVi look legitimate
- Corporate registration. MEDVi, LLC is based in Newark, Delaware.
- Licensed clinicians. Prescribing decisions are made by OpenLoop Health clinicians — a recognized nationwide telehealth provider network — after checkout.
- Named pharmacy partners. Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding are listed publicly in MEDVi's current terms.
- Public policies. Pricing, cancellation, and terms are all accessible before checkout.
- Large public review footprint. Trustpilot shows 12,000+ reviews at 4.4 / 5. Fraud operations do not sustain that review volume at that rating.
Why some people still feel uneasy
1. The FDA warning letter (February 20, 2026)
2. MEDVi's public response
3. MEDVi's own disclosure about advertising content
Reading this and still comfortable with the tradeoff?
Check your eligibility on MEDVi's free medical intake.
The biggest MEDVi semaglutide complaints, categorized
Answer capsule: Across Trustpilot, ConsumerAffairs, and Reddit threads about MEDVi, negative reviews cluster into four themes: billing and refund disputes, pricing or medication-form confusion at checkout, portal and support friction, and first-order shipping delays. Positive reviews skew toward clinician responsiveness, dose-adjustment flexibility, and quick initial approval.
| Complaint theme | What reviewers describe | How to avoid it |
|---|---|---|
| Auto-renewal billing | Being charged after intending to cancel | Cancel at least 72 hours before the billing date; get written confirmation |
| Refund friction | Multiple contacts to get a refund processed | Screenshot everything; dispute with your card issuer if unresolved after 14 days |
| Injection/tablet confusion | Enrolling in one product and expecting another | Confirm at checkout that you selected semaglutide injection |
| Portal / communication issues | Slow portal, difficulty logging in during peak periods | Use MEDVi's phone line, (323) 690-1564, as a fallback |
| First-order shipping delays | Longer than expected delivery during high-volume periods | Plan your first dose at least two weeks out, not one |
What complaints are NOT generally about
Can you cancel MEDVi semaglutide — and get a refund?
Answer capsule: You can cancel any time, but MEDVi's official cancellation and refund policy requires your cancellation request at least 72 hours before your next billing date, and cancellation alone does not trigger a refund. The same policy page explicitly states “there is no guarantee of results or effectiveness.” That language directly contradicts third-party descriptions of a 5-month money-back guarantee. If any guarantee matters to your decision, get the exact terms in writing from MEDVi before you enroll.
The 72-hour rule, in plain English
MEDVi bills on a recurring cycle. If your next scheduled billing date is Tuesday the 15th, your cancellation request needs to be in MEDVi's system by Saturday the 12th at the latest — treat that 72-hour window as a floor, not a target. Reviewers who submitted cancellation requests 24–48 hours out still report getting charged for the following cycle.
The guarantee contradiction — read this carefully
⚠️ What we verified
On MEDVi's official cancellation and refund policy page: the explicit language is: “There is no guarantee of results or effectiveness.”
On ConsumerAffairs and in third-party reviews: the program is described as including a 5-month money-back guarantee minus a 25% consultation fee — and some reviewers report the terms shifted from 3 months to 5 months between enrollment and when they tried to use it.
Our read: MEDVi's official cancellation policy takes precedence over marketing copy. Do not use the “guarantee” as your mental safety net. Treat the first $179 as the real commitment test.
The protect-yourself checklist (read this before you enroll)
- Screenshot the current pricing page — dated proof of what you signed up for.
- Screenshot the current cancellation and refund policy, including the “no guarantee of results” language.
- Set a calendar reminder four days before your next billing date — recurring every cycle.
- Confirm at checkout that you're enrolling in semaglutide injection, not tablet or tirzepatide.
- Save your order confirmation email — that's your receipt.
- If you ever cancel, cancel in writing through the portal and save the confirmation. Phone (323) 690-1564 is a secondary channel if the portal is slow.
- If you're billed after cancellation and can't resolve it within 14 days, dispute the charge with your card issuer.
Read MEDVi's current terms before you enroll
Free medical intake. First month is $179 at intake completion.
What happens after you sign up for MEDVi semaglutide
Answer capsule: Complete online medical intake → charged $179 at intake completion → OpenLoop Health clinician reviews intake and decides whether to prescribe → if prescribed, medication ships from a partner pharmacy → if medically disqualified, MEDVi's policy states a refund is issued. Independent user reports on ConsumerAffairs describe approval within 24 hours and delivery within about 8–9 days.
- 1
1. Online medical intake (10–15 minutes)
You complete a medical history form covering current weight, medications, relevant conditions, weight loss goals, and prior GLP-1 experience. GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2) — expect intake questions aligned with those class-wide contraindications.
- 2
2. Payment at intake completion
Per MEDVi's official cancellation and refund policy, the subscription begins when the intake form is completed and the customer is charged for the first month at that time. Know the charge happens at intake, not after clinician approval.
- 3
3. Clinician review
An OpenLoop Health clinician — not MEDVi directly — reviews your intake. Some reviews are asynchronous (messaging); others include a brief video visit. Per ConsumerAffairs reporting, six states (Kansas, Indiana, Mississippi, New Mexico, Oklahoma, West Virginia) reportedly require a video consult before a GLP-1 prescription.
- 4
4. Pharmacy fulfillment
Your prescription goes to one of MEDVi's named partner pharmacies — currently Triad Rx, RedRock Pharmacy, or Beaker Pharmacy & Compounding — for compounding. You can ask MEDVi support which pharmacy will fill your specific order.
- 5
5. Shipping
Medication ships with ice packs intended to maintain cold-chain temperature during transit. Independent user reports describe delivery within about 8–9 days from intake.
- 6
6. When your package arrives
The FDA has publicly flagged concerns about compounded GLP-1 injections arriving warm. If your package arrives at room temperature or warmer, or if the ice packs are fully thawed, do not use the medication — contact MEDVi support for a replacement.
- 7
7. Refills and ongoing care
Before each refill cycle, some users report a brief clinician check-in (video or messaging). Dose adjustments, side-effect management, and medication switches happen through the portal or via messaging.
Check MEDVi semaglutide availability in your state
Free medical intake. Refund if a clinician medically disqualifies you.
Is MEDVi semaglutide compounded or FDA-approved?
Answer capsule: MEDVi's semaglutide injection program is compounded, not FDA-approved as a finished product. The FDA says compounded GLP-1 drugs are not FDA-approved, do not undergo FDA premarket review for safety, effectiveness, or quality, and should only be used when a patient's needs cannot be met by an FDA-approved drug.
Why this distinction matters
FDA-approved semaglutide products are Wegovy (for chronic weight management), Ozempic (for type 2 diabetes), and Rybelsus (oral, for type 2 diabetes). These went through the full FDA approval process, including the STEP clinical trial program for Wegovy. Those trial results belong to those FDA-approved products, not to compounded versions.
FDA concerns with compounded GLP-1s (not MEDVi-specific)
| FDA concern | What it means |
|---|---|
| Dosing errors | Reports requiring hospitalization, linked to unclear labeling or concentration differences between compounded and FDA-approved products. |
| Salt-form concerns | Some compounded semaglutide products may use semaglutide sodium or semaglutide acetate — salt forms the FDA says are different active ingredients than those in the approved drugs. MEDVi's public page does not specify the exact ingredient form. |
| Temperature exposure | Improper cold-chain handling during shipping can compromise potency. |
| Mass-marketed compounding | Large-scale compounding for non-specific patients may operate outside traditional compounding law. |
| Shortage-era rules narrowed | The FDA declared the semaglutide injection shortage resolved on February 21, 2025. The broad shortage-era justification for compounding has narrowed, though patient-specific compounding remains legal. |
If you want FDA-approved semaglutide specifically, MEDVi is not the cleanest path. Skip to Alternatives →
If a compounded semaglutide path still fits what you want, start with MEDVi's medical intake
Who's actually behind MEDVi's semaglutide program?
Answer capsule: MEDVi itself is the consumer platform. The clinicians who review your intake and write prescriptions work for OpenLoop Health, a nationwide telehealth clinician network. The pharmacies that prepare and ship your compounded semaglutide are publicly named in MEDVi's current terms: Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — all U.S.-licensed compounding pharmacies.
OpenLoop Health (the clinicians)
OpenLoop Health is a telehealth infrastructure company that runs clinician networks for multiple consumer-facing platforms. The clinicians are U.S.-licensed and responsible for the prescribing decision after reviewing your intake. MEDVi is the platform; OpenLoop is the medical practice behind it.
Triad Rx
A U.S.-based compounding pharmacy listed in MEDVi's current partner terms. Note: Triad Rx is named as a defendant (alongside OpenLoop Health) in a November 2025 class-action complaint involving compounded oral tirzepatide absorption — different formulation, different molecule from semaglutide injection. Allegations in pending litigation are not proven findings.
RedRock Pharmacy
A U.S.-licensed compounding pharmacy listed in MEDVi's current terms.
Beaker Pharmacy & Compounding
Listed in MEDVi's current terms, located in McKinney, Texas. U.S.-licensed.
What real customers are actually saying about MEDVi semaglutide
Answer capsule: Across 12,000+ Trustpilot reviews (4.4 / 5 average) and 1,860 ConsumerAffairs reviews (3.4 / 5 average), common positive themes are clinician responsiveness, clear dose adjustment conversations, and fast initial approval. We use independent-platform quotes only — not MEDVi's own marketing — because MEDVi's terms disclose that some on-site imagery may involve actors or models.
“Giselle was very helpful and easy to speak with.”
— Mary Faller, Trustpilot, April 2026
“Before each new 4 week refill, you must have a video visit with a doctor.”
— Judy, verified purchase, ConsumerAffairs
What MEDVi says about semaglutide results — and the FDA side effect data
Answer capsule: MEDVi's own policy page states “there is no guarantee of results or effectiveness.” FDA-approved semaglutide data comes from the STEP clinical trial program for Wegovy — that data belongs to the FDA-approved product, not to compounded versions. Side effects are class-wide.
FDA-approved product context (separate from MEDVi)
| Product | Approval indication | Key trial data |
|---|---|---|
| Wegovy (semaglutide) | FDA-approved for chronic weight management | STEP 1 trial: avg. ~14.9% weight loss over 68 weeks (NEJM) |
| Ozempic (semaglutide) | FDA-approved for type 2 diabetes | Primary endpoint: glycemic control; weight loss is a secondary outcome |
| Compounded semaglutide (MEDVi) | Not FDA-approved as a finished product | Has not undergone individual FDA evaluation as a finished drug |
Class-wide side effects (FDA-approved semaglutide prescribing information)
Common side effects
- Nausea — most pronounced early in treatment and during dose escalation
- Constipation
- Diarrhea
- Vomiting
- Fatigue
Important safety considerations
- Boxed warning: thyroid C-cell tumors observed in rodent studies. Contraindicated with MTC or MEN2 history.
- Pancreatitis — persistent severe abdominal pain warrants medical attention
- Gallbladder disease — increased risk of gallstones with rapid weight loss
- Acute kidney injury — typically in patients with severe nausea/vomiting leading to dehydration
If a compounded semaglutide path still fits what you want, start with MEDVi's medical intake
The best alternatives if MEDVi semaglutide isn't your fit
Answer capsule: If you want FDA-approved GLP-1 access and insurance support, Ro is a cleaner path. If you want lower ongoing compounded semaglutide pricing, Eden's current public pricing is $149 first month / $229 monthly. For uncertain shoppers, our free 60-second quiz routes you to the right path.
Ro is the cleanest FDA-approved option we track. Ro Body membership is $39 for the first month, then $149/month ongoing, or as low as $74/month with annual prepay — GLP-1 medication is charged separately on top of membership. Ro carries FDA-approved GLP-1 options including Zepbound® (tirzepatide) and Foundayo™ (orforglipron), matches manufacturer pricing where applicable, and includes a dedicated insurance concierge that handles prior-authorization paperwork plus a free GLP-1 Insurance Coverage Checker.
Choose Ro if: you want FDA-approved medication, you have (or might have) insurance coverage worth trying, or you want transparent branded pricing without the compounded ambiguity.
For the full head-to-head, see our MEDVi vs Ro comparison →
Check Ro's current FDA-approved GLP-1 pricing
Eden currently lists compounded semaglutide at $149 first month / $229 monthly on the month-to-month plan, or $129 first month / $209 monthly on a 3-month plan. No separate membership fee advertised on Eden's current GLP-1 page. On monthly pricing, Eden's ongoing rate is lower than MEDVi's $299 refill — a meaningful annual difference for long-term users.
Choose Eden if: you're comfortable with compounded medication, you want a lower ongoing compounded price, and you don't need MEDVi's specific features.
For the side-by-side, see our Eden vs MEDVi comparison →
See Eden's current compounded semaglutide pricing
MEDVi Pills (oral semaglutide)
If you landed here wanting tablets, this isn't the right page.
MEDVi Pills Reviews →MEDVi Tirzepatide
If you've decided tirzepatide is a better starting point for you.
MEDVi Tirzepatide Reviews →How we verified this review
Answer capsule: We checked MEDVi's live public pages (semaglutide program page, terms and conditions, cancellation and refund policy, public communication page), the FDA's public Warning Letters database for letter #721455, live Trustpilot and ConsumerAffairs snapshots, Ro's public pricing page, Eden's public GLP-1 page, and FDA guidance on compounded GLP-1 medications. We flagged any claim we couldn't confirm in writing.
Sources we checked (April 22, 2026)
- MEDVi's public semaglutide program page (home.medvi.org and glp.medvi.org)
- MEDVi terms and conditions
- MEDVi cancellation and refund policy
- MEDVi public communication page
- FDA Warning Letters database — letter #721455, MEDVi, LLC, 02/20/2026
- FDA guidance on compounded GLP-1 medications and salt-form concerns
- FDA drug shortage list (semaglutide injection shortage resolved 02/21/2025)
- Trustpilot live snapshot — medvi.org profile
- ConsumerAffairs live snapshot — medvi profile
- Ro pricing page (weight loss pricing)
- Eden GLP-1 treatments page
- Wegovy and Ozempic prescribing information (for FDA-approved comparison context)
What we flagged as needing verification
- MEDVi's “5-month results guarantee” — described by ConsumerAffairs and third parties, but contradicted by MEDVi's own cancellation policy language. Get any guarantee terms in writing before enrolling.
- Multi-month plan pricing for semaglutide injections — some affiliate pages cite $249/3-mo and $219/6-mo plans; not confirmed on MEDVi's current public pricing page.
- Exact ingredient form (base semaglutide vs salt form) — not publicly specified on MEDVi's program page. If this matters to you, ask MEDVi support and request a Certificate of Analysis.
- State-by-state availability — MEDVi's terms say “certain states;” ConsumerAffairs reports 49 states excluding North Dakota.
MEDVi semaglutide FAQ
The final verdict
If you've read this far, you already know whether MEDVi semaglutide is your fit.
For the cash-pay adult who wants a fast bundled start in telehealth GLP-1, who is comfortable with compounded medication, who understands the first month is charged at intake completion, and who can set a four-day-before-billing calendar reminder — MEDVi's semaglutide injection program is one of the most accessible compounded paths in 2026 at $179 first month and $299 refills. The billing complaints are real and worth planning around. The FDA warning letter was about promotional claims, not a recall. The cancellation policy is stricter than most people expect.
If the cleanest compliance story is your top priority, Ro is cleaner. If the lowest ongoing compounded price is your priority, Eden is lower on monthly pricing. If you want something different, take the quiz below.
Everyone else — this is the path.
Free medical intake. First month is $179 at intake completion. MEDVi's policy states a refund is issued if a clinician medically disqualifies you.
Check your eligibility for MEDVi's semaglutide programStill not sure which GLP-1 program is right for you?
Take our free 60-second GLP-1 matching quizSix quick questions. We route you to your best path. No email required to get your result.
About this review
Written by the Weight Loss Provider Guide Editorial Team. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.
How this page was produced: We verified MEDVi's current public pricing, program details, cancellation and refund policy, pharmacy partner disclosures, and regulatory history directly against the company's own live pages and the FDA's public Warning Letters database. We compared MEDVi's semaglutide injection program against current competitor pricing at Ro and Eden, and cross-referenced real user reviews on Trustpilot and ConsumerAffairs. We did not use MEDVi's own marketing testimonials because MEDVi's terms disclose that some on-site content may involve actors, models, or AI-enhanced imagery.
Affiliate disclosure: This page contains affiliate links. If you enroll with MEDVi, Ro, or Eden through our links, we may receive a commission at no additional cost to you. Our verdict on MEDVi did not change based on commission rates. We verified pricing and policies first, then wrote the review.
This content is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved as finished products. GLP-1 medications are prescription treatments requiring evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any weight loss treatment.
First published: April 22, 2026. Last verified: April 22, 2026. Next scheduled verification: May 22, 2026.